Mai Liande: At present, the proportion of revenue from sports rehabilitation products is relatively small and has not yet had a significant impact on the company's performance.
Announcement from MaiLande: The company's stock trading has seen a deviation of 30% in the closing price over three consecutive trading days, which is considered abnormal fluctuation in stock trading. The company is mainly engaged in research, development, production, and sales of medical devices related to pelvic floor and gynecological rehabilitation. Its main products include pelvic floor and gynecological rehabilitation, reproductive rehabilitation, anti-aging, sports rehabilitation, consumables, and information products. Currently, the revenue from sports rehabilitation products is relatively small and has not had a significant impact on the company's performance.
Latest